Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TORNADO: Dupilumab vs Mepolizumab in CRSwNP
NCT05942222Phase 4Active, not recruiting
- Sponsor
- Rigshospitalet
- Start
- Apr 2023
- Primary completion
- Apr 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of dupilumab in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by Rigshospitalet. Started Apr 2023; status: active, not recruiting.
02
Drugs
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT05942222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05942222.